In summary, PDE inhibitors besides their anti-inflammatory and bronchodilator properties can prevent recurrent infection, persistent inflammation, and decline in lung functions via direct cilia-stimulatory response, when cilia dysfunction in lung diseases has developed. The gene discussed is ALDH7A1; the disease is infection.